[go: up one dir, main page]

NO913659D0 - INHIBITION OF HIV BY USING SYNERGISTIC COMBINATIONS OF NUCLEOSIDE DERIVATIVES. - Google Patents

INHIBITION OF HIV BY USING SYNERGISTIC COMBINATIONS OF NUCLEOSIDE DERIVATIVES.

Info

Publication number
NO913659D0
NO913659D0 NO913659A NO913659A NO913659D0 NO 913659 D0 NO913659 D0 NO 913659D0 NO 913659 A NO913659 A NO 913659A NO 913659 A NO913659 A NO 913659A NO 913659 D0 NO913659 D0 NO 913659D0
Authority
NO
Norway
Prior art keywords
hiv
inhibition
nucleoside derivatives
synergistic combinations
synergistic
Prior art date
Application number
NO913659A
Other languages
Norwegian (no)
Other versions
NO913659L (en
Inventor
Vera Brankovan
Richard J White
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen filed Critical Oncogen
Publication of NO913659D0 publication Critical patent/NO913659D0/en
Publication of NO913659L publication Critical patent/NO913659L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO91913659A 1989-03-17 1991-09-17 INHIBITION OF HIV BY USING SYNERGISTIC COMBINATIONS OF NUCLEOSIDE DERIVATIVES. NO913659L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32493489A 1989-03-17 1989-03-17
US40190889A 1989-09-01 1989-09-01
PCT/US1990/001424 WO1990011081A1 (en) 1989-03-17 1990-03-16 Inhibition of hiv using synergistic combinations of nucleoside derivatives

Publications (2)

Publication Number Publication Date
NO913659D0 true NO913659D0 (en) 1991-09-17
NO913659L NO913659L (en) 1991-10-18

Family

ID=26984692

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91913659A NO913659L (en) 1989-03-17 1991-09-17 INHIBITION OF HIV BY USING SYNERGISTIC COMBINATIONS OF NUCLEOSIDE DERIVATIVES.

Country Status (19)

Country Link
EP (1) EP0464137A4 (en)
JP (1) JPH04504850A (en)
KR (1) KR920700653A (en)
CN (1) CN1045791A (en)
AU (1) AU5351490A (en)
CA (1) CA2050473A1 (en)
DD (1) DD301787A9 (en)
FI (1) FI914367A0 (en)
GR (1) GR1000618B (en)
HU (1) HU208254B (en)
IL (1) IL93783A0 (en)
NO (1) NO913659L (en)
NZ (1) NZ232912A (en)
OA (1) OA09555A (en)
PL (1) PL284343A1 (en)
PT (1) PT93449A (en)
WO (1) WO1990011081A1 (en)
YU (1) YU53790A (en)
ZW (1) ZW3290A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2083668T5 (en) * 1991-05-16 2001-06-16 Glaxo Group Ltd ANTIVIRICAL COMBINATIONS CONTAINING NUCLEOSIDE ANALOGS.
EP1089741A1 (en) * 1998-06-24 2001-04-11 Emory University Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
US6914052B2 (en) 2001-03-15 2005-07-05 The Trustees Of Boston College Selective anti-viral nucleoside chain terminators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62501712A (en) * 1985-08-26 1987-07-09 アメリカ合衆国 Anti-HTLV-3/LAV agent containing 2',3'-dideoxyinosine, 2',3'-dideoxyguanosine or 2',3'-dideoxyadenosine
GB8712115D0 (en) * 1987-05-22 1987-06-24 Hoffmann La Roche Pyrimidine derivatives
US4837311A (en) * 1987-06-22 1989-06-06 Hoffman-La Roche Inc. Anti-retroviral compounds
NZ226672A (en) * 1987-10-30 1991-07-26 Hoffmann La Roche 6-amino-9-(2,3-dideoxy-2-fluoro-b-d-threopentofuranosyl)-9h-purine derivatives and pharmaceutical compositions
US4908440A (en) * 1987-11-12 1990-03-13 Bristol Myers Company 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides

Also Published As

Publication number Publication date
HU208254B (en) 1993-09-28
PL284343A1 (en) 1991-06-03
NO913659L (en) 1991-10-18
PT93449A (en) 1990-11-07
WO1990011081A1 (en) 1990-10-04
CA2050473A1 (en) 1990-09-18
AU5351490A (en) 1990-10-22
HU902898D0 (en) 1991-12-30
HUT57988A (en) 1992-01-28
FI914367A0 (en) 1991-09-17
GR900100189A (en) 1990-07-31
YU53790A (en) 1993-05-28
EP0464137A1 (en) 1992-01-08
OA09555A (en) 1993-01-31
GR1000618B (en) 1992-08-31
DD301787A9 (en) 1994-01-13
CN1045791A (en) 1990-10-03
JPH04504850A (en) 1992-08-27
EP0464137A4 (en) 1992-01-15
KR920700653A (en) 1992-08-10
ZW3290A1 (en) 1990-11-07
IL93783A0 (en) 1990-12-23
NZ232912A (en) 1992-06-25

Similar Documents

Publication Publication Date Title
NO885106L (en) PROCEDURE FOR THE PREPARATION OF CYTIDINE DERIVATIVES.
DE3864582D1 (en) ALKOXY-SUBSTITUTED DIHYDROBENZYPYRANE-2-CARBOXYLATE DERIVATIVES.
NO852994L (en) PROCEDURE FOR THE PREPARATION OF GLUTARAMIDE DERIVATIVES.
DE69008682D1 (en) Guanidinobenzene derivatives.
NO900742L (en) COMPOSITION OF WORK BENEFITS.
NO930047D0 (en) HIV INHIBITIVE BENZENACETAMIDE DERIVATIVES
ATE124407T1 (en) CHROMEDER DERIVATIVES.
DE69017383D1 (en) SUBSTITUTED BICYCLOHEPTADION DERIVATIVES.
ATE116985T1 (en) CHROMEDER DERIVATIVES.
DE69017657D1 (en) PYRIDE DERIVATIVES.
NO854655L (en) PROCEDURE FOR THE PREPARATION OF FLAVOL SIGNATURE DERIVATIVES.
NO913659D0 (en) INHIBITION OF HIV BY USING SYNERGISTIC COMBINATIONS OF NUCLEOSIDE DERIVATIVES.
DE59000510D1 (en) N-PHENYLTETRAHYDROINDAZOLE DERIVATIVES.
DE69005904D1 (en) Phenylpyrimidone derivatives.
FI912963A0 (en) OEKANDE PYRIMIDINE DERIVATIVES OF HJAERNVERKSAMHETEN.
DE59003499D1 (en) 3-cyano-4-phenyl-pyrrole derivatives.
DE69002136D1 (en) SACCHARID DERIVATIVES OF PROTOCATECHUALDEHYD.
DE69004844D1 (en) Pyrimidine derivatives.
DE69015726D1 (en) Piperidylthiocarbapenem derivatives.
OA08742A (en) Pyrimidine derivatives.
DE69001450D1 (en) DIHYDROXYNAPHTHALINE DERIVATIVES.
ZM990A1 (en) Inhibition of hiv using synergistic combinations of nucleoside derivatives
MX19365A (en) DERIVATIVES OF TETRAHIDROBENCIMIDAZOL.
NO912341D0 (en) PROCEDURE FOR THE PREPARATION OF HIV REVERS TRANSCIPTASE INHIBITORS.
ES1021294Y (en) MUNECO OF DOUBLE USE.